Nowadays, the production and operation mode of pharmaceutical companies has undergone tremendous changes. The traditional production methods have gradually been replaced by intelligent, automated and information-based production methods. Therefore, in the new era of “window”, pharmaceutical machinery and equipment enterprises also need to constantly change. The concept of eliminating backward production methods and transitioning to the high end.

It is understood that China's pharmaceutical machinery started late, most of them are based on imitation, and the technology is relatively backward. However, in recent years, with the promulgation of the national favorable policies, the development of China's pharmaceutical machinery and equipment industry has also been significantly improved. In the past, the situation of almost all domestic high-end pharmaceutical equipment for imported products began to reverse. Nowadays, with the continuous research and development and innovation of domestic pharmaceutical companies, a considerable number of high-end pharmaceutical machinery and equipment products have been localized, and the industrial upgrading of the pharmaceutical industry has been vigorously promoted.

However, some insiders pointed out that although China's pharmaceutical machinery and equipment industry has made great progress, the core technology is still lacking, and related technologies still need to be further improved. Taking the pulverizer as an example, although China's pulverizer industry has made great progress, its deep processing technology has been continuously improved, narrowing the gap with industrial developed countries, but the pulverizing effect of materials with higher hardness and higher viscosity is not very mature. Mainly in the product granularity is not fine enough, not uniform enough in two aspects. Mr. Zhang, an industry insider, said that the crusher products must break through this level and still need to take the high-end route, constantly innovate technology, and strive to reduce the product size and achieve a finer crushing effect.

Along with the deepening of the reform of the drug supply side and the upgrading of drug consumption, the pharmaceutical industry will usher in the opportunity of reshuffling. They will accelerate the pace of structural adjustment. The pharmaceutical machinery and equipment enterprises should also seize the opportunity to continuously adjust the structure. Take the high-end route, strengthen technological innovation, and help pharmaceutical industry enterprises become bigger and stronger.

Some experts pointed out that after the end of GMP certification, the number of domestic pharmaceutical companies will be reduced, but the comprehensive level, production capacity and product quality will be greatly improved, which puts higher requirements on pharmaceutical machinery, so pharmaceutical companies must do Big and strong, develop high-end routes, match the strength and scale of pharmaceutical companies.